Targeting TP53 in triple-negative breast cancer: Molecular pathogenesis, therapeutic implications, and emerging pharmacological strategies. // Bulletin du Cancer. – URL: https://www.sciencedirect.com/science/article/pii/S0007455126003206?dgcid=rss_sd_all
Targeting TP53 in triple-negative breast cancer: Molecular pathogenesis, therapeutic implications, and emerging pharmacological strategies. Bulletin du Cancer. https://www.sciencedirect.com/science/article/pii/S0007455126003206?dgcid=rss_sd_all
“Targeting TP53 in triple-negative breast cancer: Molecular pathogenesis, therapeutic implications, and emerging pharmacological strategies.” Bulletin du Cancer.
@article{article39364,
title = {Targeting TP53 in triple-negative breast cancer: Molecular pathogenesis, therapeutic implications, and emerging pharmacological strategies},
journal = {Bulletin du Cancer},
url = {https://www.sciencedirect.com/science/article/pii/S0007455126003206?dgcid=rss_sd_all}
}